サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1127545

世界の子宮癌治療および診断市場：考察と予測 (2028年まで)

Global Uterine Cancer Therapies and Diagnostic Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 91 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の子宮癌治療および診断市場：考察と予測 (2028年まで)
出版日: 2022年09月22日
発行: QYResearch
ページ情報: 英文 91 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、子宮癌治療および診断 (Uterine Cancer Therapies and Diagnostic) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の子宮癌治療および診断の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Uterine Sarcomas
    • Endometrial Carcinomas
  • 市場：アプリケーション別
    • 世界の子宮癌治療および診断の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の子宮癌治療および診断の市場展望 (2017-2028)
  • 子宮癌治療および診断の市場成長トレンド：地域別
    • 子宮癌治療および診断 市場規模：地域別: 2017 VS 2021 VS 2028
    • 子宮癌治療および診断の市場規模実績：地域別 (2017-2022)
    • 子宮癌治療および診断の市場規模予測：地域別 (2023-2028)
  • 子宮癌治療および診断 市場動向
    • 子宮癌治療および診断 業界動向
    • 子宮癌治療および診断 市場の促進要因
    • 子宮癌治療および診断 市場の課題
    • 子宮癌治療および診断 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の子宮癌治療および診断の上位企業：収益別
    • 世界の子宮癌治療および診断の上位企業：収益別 (2017-2022)
    • 世界の子宮癌治療および診断の収益シェア：企業別 (2017-2022)
  • 世界の子宮癌治療および診断の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：子宮癌治療および診断の収益
  • 世界の子宮癌治療および診断 市場集中度
    • 世界の子宮癌治療および診断 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 子宮癌治療および診断の収益 2021
  • 子宮癌治療および診断の主要企業の本社および事業エリア
  • 主要企業 子宮癌治療および診断の製品ソリューションおよびサービス
  • 市場参入時期： 子宮癌治療および診断 市場
  • M&A, 拡張計画

第4章 子宮癌治療および診断 内訳データ：タイプ別

  • 世界の子宮癌治療および診断の市場規模実績：タイプ別 (2017-2022)
  • 世界の子宮癌治療および診断の市場規模予測：タイプ別 (2023-2028)

第5章 子宮癌治療および診断 内訳データ：アプリケーション別

  • 世界の子宮癌治療および診断の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の子宮癌治療および診断の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の子宮癌治療および診断 市場規模 (2017-2028)
  • 北米の子宮癌治療および診断 市場規模：タイプ別
    • 北米の子宮癌治療および診断 市場規模：タイプ別 (2017-2022)
    • 北米の子宮癌治療および診断 市場規模：タイプ別 (2023-2028)
    • 北米の子宮癌治療および診断の市場シェア：タイプ別 (2017-2028)
  • 北米の子宮癌治療および診断 市場規模：アプリケーション別
    • 北米の子宮癌治療および診断 市場規模：アプリケーション別 (2017-2022)
    • 北米の子宮癌治療および診断 市場規模：アプリケーション別 (2023-2028)
    • 北米の子宮癌治療および診断の市場シェア：アプリケーション別 (2017-2028)
  • 北米の子宮癌治療および診断 市場規模：国別
    • 北米の子宮癌治療および診断 市場規模：国別 (2017-2022)
    • 北米の子宮癌治療および診断 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の子宮癌治療および診断 市場規模 (2017-2028)
  • 欧州の子宮癌治療および診断 市場規模：タイプ別
    • 欧州の子宮癌治療および診断 市場規模：タイプ別 (2017-2022)
    • 欧州の子宮癌治療および診断 市場規模：タイプ別 (2023-2028)
    • 欧州の子宮癌治療および診断の市場シェア：タイプ別 (2017-2028)
  • 欧州の子宮癌治療および診断 市場規模：アプリケーション別
    • 欧州の子宮癌治療および診断 市場規模：アプリケーション別 (2017-2022)
    • 欧州の子宮癌治療および診断 市場規模：アプリケーション別 (2023-2028)
    • 欧州の子宮癌治療および診断の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の子宮癌治療および診断 市場規模：国別
    • 欧州の子宮癌治療および診断 市場規模：国別 (2017-2022)
    • 欧州の子宮癌治療および診断 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 子宮癌治療および診断 市場規模 (2017-2028)
  • アジア太平洋地域 子宮癌治療および診断 市場規模：タイプ別
    • アジア太平洋地域 子宮癌治療および診断 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 子宮癌治療および診断 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 子宮癌治療および診断の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 子宮癌治療および診断 市場規模：アプリケーション別
    • アジア太平洋地域 子宮癌治療および診断 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 子宮癌治療および診断 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 子宮癌治療および診断の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 子宮癌治療および診断 市場規模：地域別
    • アジア太平洋地域 子宮癌治療および診断 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 子宮癌治療および診断 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの子宮癌治療および診断 市場規模 (2017-2028)
  • ラテンアメリカの子宮癌治療および診断 市場規模：タイプ別
    • ラテンアメリカの子宮癌治療および診断 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの子宮癌治療および診断 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの子宮癌治療および診断の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの子宮癌治療および診断 市場規模：アプリケーション別
    • ラテンアメリカの子宮癌治療および診断 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの子宮癌治療および診断 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの子宮癌治療および診断の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの子宮癌治療および診断 市場規模：国別
    • ラテンアメリカの子宮癌治療および診断 市場規模：国別 (2017-2022)
    • ラテンアメリカの子宮癌治療および診断 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの子宮癌治療および診断 市場規模 (2017-2028)
  • 中東・アフリカの子宮癌治療および診断 市場規模：タイプ別
    • 中東・アフリカの子宮癌治療および診断 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの子宮癌治療および診断 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの子宮癌治療および診断の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの子宮癌治療および診断 市場規模：アプリケーション別
    • 中東・アフリカの子宮癌治療および診断 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの子宮癌治療および診断 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの子宮癌治療および診断の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの子宮癌治療および診断 市場規模：国別
    • 中東・アフリカの子宮癌治療および診断 市場規模：国別 (2017-2022)
    • 中東・アフリカの子宮癌治療および診断 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Ariad Pharmaceuticals
  • Merck
  • AbbVie
  • BD

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Uterine Sarcomas
  • Table 3. Key Players of Endometrial Carcinomas
  • Table 4. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Uterine Cancer Therapies and Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Uterine Cancer Therapies and Diagnostic Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Uterine Cancer Therapies and Diagnostic Market Share by Region (2017-2022)
  • Table 8. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Uterine Cancer Therapies and Diagnostic Market Share by Region (2023-2028)
  • Table 10. Uterine Cancer Therapies and Diagnostic Market Trends
  • Table 11. Uterine Cancer Therapies and Diagnostic Market Drivers
  • Table 12. Uterine Cancer Therapies and Diagnostic Market Challenges
  • Table 13. Uterine Cancer Therapies and Diagnostic Market Restraints
  • Table 14. Global Uterine Cancer Therapies and Diagnostic Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Uterine Cancer Therapies and Diagnostic Revenue Share by Players (2017-2022)
  • Table 16. Global Top Uterine Cancer Therapies and Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Cancer Therapies and Diagnostic as of 2021)
  • Table 17. Ranking of Global Top Uterine Cancer Therapies and Diagnostic Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Uterine Cancer Therapies and Diagnostic Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Uterine Cancer Therapies and Diagnostic Product Solution and Service
  • Table 21. Date of Enter into Uterine Cancer Therapies and Diagnostic Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Type (2017-2022)
  • Table 25. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Type (2023-2028)
  • Table 27. Global Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Uterine Cancer Therapies and Diagnostic Revenue Share by Application (2017-2022)
  • Table 29. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Uterine Cancer Therapies and Diagnostic Revenue Share by Application (2023-2028)
  • Table 31. North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Ariad Pharmaceuticals Company Details
  • Table 62. Ariad Pharmaceuticals Business Overview
  • Table 63. Ariad Pharmaceuticals Uterine Cancer Therapies and Diagnostic Product
  • Table 64. Ariad Pharmaceuticals Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022) & (US$ Million)
  • Table 65. Ariad Pharmaceuticals Recent Developments
  • Table 66. Merck Company Details
  • Table 67. Merck Business Overview
  • Table 68. Merck Uterine Cancer Therapies and Diagnostic Product
  • Table 69. Merck Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022) & (US$ Million)
  • Table 70. Merck Recent Developments
  • Table 71. AbbVie Company Details
  • Table 72. AbbVie Business Overview
  • Table 73. AbbVie Uterine Cancer Therapies and Diagnostic Product
  • Table 74. AbbVie Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022) & (US$ Million)
  • Table 75. AbbVie Recent Developments
  • Table 76. BD Company Details
  • Table 77. BD Business Overview
  • Table 78. BD Uterine Cancer Therapies and Diagnostic Product
  • Table 79. BD Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022) & (US$ Million)
  • Table 80. BD Recent Developments
  • Table 81. Research Programs/Design for This Report
  • Table 82. Key Data Information from Secondary Sources
  • Table 83. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Uterine Cancer Therapies and Diagnostic Market Share by Type: 2021 VS 2028
  • Figure 2. Uterine Sarcomas Features
  • Figure 3. Endometrial Carcinomas Features
  • Figure 4. Global Uterine Cancer Therapies and Diagnostic Market Share by Application: 2021 VS 2028
  • Figure 5. Hospitals Case Studies
  • Figure 6. Ambulatory Surgical Centers Case Studies
  • Figure 7. Specialty Clinics Case Studies
  • Figure 8. Others Case Studies
  • Figure 9. Uterine Cancer Therapies and Diagnostic Report Years Considered
  • Figure 10. Global Uterine Cancer Therapies and Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Uterine Cancer Therapies and Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Uterine Cancer Therapies and Diagnostic Market Share by Region: 2021 VS 2028
  • Figure 13. Global Uterine Cancer Therapies and Diagnostic Market Share by Players in 2021
  • Figure 14. Global Top Uterine Cancer Therapies and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Cancer Therapies and Diagnostic as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Uterine Cancer Therapies and Diagnostic Revenue in 2021
  • Figure 16. North America Uterine Cancer Therapies and Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Uterine Cancer Therapies and Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Uterine Cancer Therapies and Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Uterine Cancer Therapies and Diagnostic Market Size Share by Country (2017-2028)
  • Figure 20. United States Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Uterine Cancer Therapies and Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Uterine Cancer Therapies and Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Uterine Cancer Therapies and Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Uterine Cancer Therapies and Diagnostic Market Size Share by Country (2017-2028)
  • Figure 26. Germany Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Uterine Cancer Therapies and Diagnostic Market Size Share by Region (2017-2028)
  • Figure 36. China Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Uterine Cancer Therapies and Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Uterine Cancer Therapies and Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Uterine Cancer Therapies and Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Uterine Cancer Therapies and Diagnostic Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Uterine Cancer Therapies and Diagnostic Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Ariad Pharmaceuticals Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
  • Figure 56. Merck Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
  • Figure 57. AbbVie Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
  • Figure 58. BD Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
  • Figure 59. Bottom-up and Top-down Approaches for This Report
  • Figure 60. Data Triangulation
  • Figure 61. Key Executives Interviewed
目次

This research report focuses on the Uterine Cancer Therapies and Diagnostic Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Uterine Sarcomas
    • 1.2.3 Endometrial Carcinomas
  • 1.3 Market by Application
    • 1.3.1 Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centers
    • 1.3.4 Specialty Clinics
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Uterine Cancer Therapies and Diagnostic Market Perspective (2017-2028)
  • 2.2 Uterine Cancer Therapies and Diagnostic Growth Trends by Region
    • 2.2.1 Uterine Cancer Therapies and Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Uterine Cancer Therapies and Diagnostic Historic Market Size by Region (2017-2022)
    • 2.2.3 Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Region (2023-2028)
  • 2.3 Uterine Cancer Therapies and Diagnostic Market Dynamics
    • 2.3.1 Uterine Cancer Therapies and Diagnostic Industry Trends
    • 2.3.2 Uterine Cancer Therapies and Diagnostic Market Drivers
    • 2.3.3 Uterine Cancer Therapies and Diagnostic Market Challenges
    • 2.3.4 Uterine Cancer Therapies and Diagnostic Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Uterine Cancer Therapies and Diagnostic Players by Revenue
    • 3.1.1 Global Top Uterine Cancer Therapies and Diagnostic Players by Revenue (2017-2022)
    • 3.1.2 Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Players (2017-2022)
  • 3.2 Global Uterine Cancer Therapies and Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Uterine Cancer Therapies and Diagnostic Revenue
  • 3.4 Global Uterine Cancer Therapies and Diagnostic Market Concentration Ratio
    • 3.4.1 Global Uterine Cancer Therapies and Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Uterine Cancer Therapies and Diagnostic Revenue in 2021
  • 3.5 Uterine Cancer Therapies and Diagnostic Key Players Head office and Area Served
  • 3.6 Key Players Uterine Cancer Therapies and Diagnostic Product Solution and Service
  • 3.7 Date of Enter into Uterine Cancer Therapies and Diagnostic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Cancer Therapies and Diagnostic Breakdown Data by Type

  • 4.1 Global Uterine Cancer Therapies and Diagnostic Historic Market Size by Type (2017-2022)
  • 4.2 Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Type (2023-2028)

5 Uterine Cancer Therapies and Diagnostic Breakdown Data by Application

  • 5.1 Global Uterine Cancer Therapies and Diagnostic Historic Market Size by Application (2017-2022)
  • 5.2 Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Uterine Cancer Therapies and Diagnostic Market Size (2017-2028)
  • 6.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Type
    • 6.2.1 North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022)
    • 6.2.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028)
    • 6.2.3 North America Uterine Cancer Therapies and Diagnostic Market Share by Type (2017-2028)
  • 6.3 North America Uterine Cancer Therapies and Diagnostic Market Size by Application
    • 6.3.1 North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022)
    • 6.3.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028)
    • 6.3.3 North America Uterine Cancer Therapies and Diagnostic Market Share by Application (2017-2028)
  • 6.4 North America Uterine Cancer Therapies and Diagnostic Market Size by Country
    • 6.4.1 North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022)
    • 6.4.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Uterine Cancer Therapies and Diagnostic Market Size (2017-2028)
  • 7.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Type
    • 7.2.1 Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022)
    • 7.2.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028)
    • 7.2.3 Europe Uterine Cancer Therapies and Diagnostic Market Share by Type (2017-2028)
  • 7.3 Europe Uterine Cancer Therapies and Diagnostic Market Size by Application
    • 7.3.1 Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022)
    • 7.3.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028)
    • 7.3.3 Europe Uterine Cancer Therapies and Diagnostic Market Share by Application (2017-2028)
  • 7.4 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country
    • 7.4.1 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022)
    • 7.4.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size (2017-2028)
  • 8.2 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Type
    • 8.2.1 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Application
    • 8.3.1 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region
    • 8.4.1 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Uterine Cancer Therapies and Diagnostic Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Uterine Cancer Therapies and Diagnostic Market Size (2017-2028)
  • 9.2 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type
    • 9.2.1 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022)
    • 9.2.2 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028)
    • 9.2.3 Latin America Uterine Cancer Therapies and Diagnostic Market Share by Type (2017-2028)
  • 9.3 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application
    • 9.3.1 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022)
    • 9.3.2 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028)
    • 9.3.3 Latin America Uterine Cancer Therapies and Diagnostic Market Share by Application (2017-2028)
  • 9.4 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country
    • 9.4.1 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022)
    • 9.4.2 Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size (2017-2028)
  • 10.2 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Type
    • 10.2.1 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Application
    • 10.3.1 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country
    • 10.4.1 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Uterine Cancer Therapies and Diagnostic Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Ariad Pharmaceuticals
    • 11.1.1 Ariad Pharmaceuticals Company Details
    • 11.1.2 Ariad Pharmaceuticals Business Overview
    • 11.1.3 Ariad Pharmaceuticals Uterine Cancer Therapies and Diagnostic Introduction
    • 11.1.4 Ariad Pharmaceuticals Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
    • 11.1.5 Ariad Pharmaceuticals Recent Developments
  • 11.2 Merck
    • 11.2.1 Merck Company Details
    • 11.2.2 Merck Business Overview
    • 11.2.3 Merck Uterine Cancer Therapies and Diagnostic Introduction
    • 11.2.4 Merck Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
    • 11.2.5 Merck Recent Developments
  • 11.3 AbbVie
    • 11.3.1 AbbVie Company Details
    • 11.3.2 AbbVie Business Overview
    • 11.3.3 AbbVie Uterine Cancer Therapies and Diagnostic Introduction
    • 11.3.4 AbbVie Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
    • 11.3.5 AbbVie Recent Developments
  • 11.4 BD
    • 11.4.1 BD Company Details
    • 11.4.2 BD Business Overview
    • 11.4.3 BD Uterine Cancer Therapies and Diagnostic Introduction
    • 11.4.4 BD Revenue in Uterine Cancer Therapies and Diagnostic Business (2017-2022)
    • 11.4.5 BD Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer